Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.9.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.9.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.16.22NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.22NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.76NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.76NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.39NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.39NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5.43NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.43NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
GY.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GY.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
AY.3 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.3 (Delta)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.18.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-18194.4China
JN.1.18.7NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
MB.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
MB.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LE.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LE.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LE.1.3.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LE.1.3.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XDR.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XDR.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.49.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.49.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
EG.5.1.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.5.1.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
HV.1.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HV.1.6NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
XBB.1.16.11NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.11NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LF.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LF.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
MD.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
MD.1.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
LP.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
LP.3NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
JN.1.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
JN.1.5NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
DL.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DL.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BA.5.1.15NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.5.1.15NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
B.1.1.529 (Omicron)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.529 (Omicron)NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
BF.41.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BF.41.1NChan-NTTGGATCTTTGTCATCCAATTTG2334.782930629284R-21867.4China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used